Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

164 Results
Title Sort descending Activity Code Posting Date Expiration Date
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)- RFA-AI-22-038 P01 May 27, 2022 October 14, 2022
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-21-155 R15 May 19, 2021 May 08, 2024
Administrative Supplement for Research on Dietary Supplements (Admin Supp, Clinical Trial Not Allowed)- PA-20-227 Supp June 09, 2020 April 16, 2023
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)- PA-20-272 Supp October 13, 2020 July 24, 2023
Administrative Supplements To Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-21-345 Supp September 10, 2021 September 10, 2024
Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)- RFA-AI-22-054 U01 August 09, 2022 December 01, 2022
Biomedical Data Repository (U24 Clinical Trials Not Allowed)- PAR-20-089 U24 January 17, 2020 May 09, 2023
Biomedical Knowledgebase (U24 Clinical Trials Not Allowed)- PAR-20-097 U24 January 17, 2020 May 09, 2023
CCRP Initiative—Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)- RFA-ES-21-006 R01 June 25, 2021 September 21, 2023
CCRP Initiative—Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)- PAR-22-209 UG3/UH3 July 06, 2022 October 18, 2024
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)- PA-21-268 June 30, 2021 July 01, 2024
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)- PAR-20-253 R21 July 07, 2020 May 31, 2023
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)- PAR-20-316 U54 December 21, 2020 September 13, 2023
Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)- PAR-21-070 R61/R33 November 13, 2020 March 18, 2023
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)- PAR-20-298 R01 September 09, 2020 December 08, 2023
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 R01 May 10, 2022 May 08, 2025
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 R21 May 10, 2022 May 08, 2025
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)- PAR-21-109 R21 January 11, 2021 May 08, 2024
Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)- RFA-AI-21-020 U01 March 17, 2021 July 07, 2023
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement, Clinical Trial Optional)- PA-20-135 Supp March 10, 2020 September 08, 2025
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)- RFA-AI-21-035 R21 March 17, 2021 July 07, 2023
Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 R01 October 24, 2019 September 08, 2022
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)- PAR-21-037 G11 October 20, 2020 July 29, 2023
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)- PAR-21-120 D43 February 17, 2021 August 04, 2023
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-21-024 P01 September 03, 2020 March 16, 2023